关注
Gaurav Joshi
Gaurav Joshi
Hemvati Nandan Bahuguna Garhwal (A Central) University
在 hnbgu.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
US FDA approved drugs from 2015–June 2020: a perspective
P Bhutani, G Joshi, N Raja, N Bachhav, PK Rajanna, H Bhutani, AT Paul, ...
Journal of Medicinal Chemistry 64 (5), 2339-2381, 2021
3922021
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
R Poduri, G Joshi, G Jagadeesh
Cellular signalling 74, 109721, 2020
1612020
Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases
R Kumar, G Joshi, H Kler, S Kalra, M Kaur, R Arya
Medicinal Research Reviews 38 (4), 1073-1125, 2018
972018
Structural insights of cyclin dependent kinases: implications in design of selective inhibitors
S Kalra, G Joshi, A Munshi, R Kumar
European journal of medicinal chemistry 142, 424-458, 2017
792017
Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
G Joshi, PK Singh, A Negi, A Rana, S Singh, R Kumar
Chemico-biological interactions 240, 120-133, 2015
702015
A review on pharmacophoric designs of antiproliferative agents
A Rana, JM Alex, M Chauhan, G Joshi, R Kumar
Medicinal Chemistry Research 24, 903-920, 2015
652015
Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics
I Khan, G Joshi, KT Nakhate, Ajazuddin, R Kumar, U Gupta
Pharmaceutical research 36, 1-17, 2019
592019
Imine/amide–imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via …
A Negi, JM Alex, SM Amrutkar, AT Baviskar, G Joshi, S Singh, ...
Bioorganic & medicinal chemistry 23 (17), 5654-5661, 2015
542015
Pyrimidine-fused derivatives: Synthetic strategies and medicinal attributes
G Joshi, H Nayyar, J Marin Alex, G S Vishwakarma, S Mittal, R Kumar
Current Topics in Medicinal Chemistry 16 (28), 3175-3210, 2016
372016
Relay tricyclic Pd (ii)/Ag (i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR
DM Sawant, S Sharma, RS Pathare, G Joshi, S Kalra, S Sukanya, ...
Chemical Communications 54 (82), 11530-11533, 2018
332018
Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold
M Chauhan, G Joshi, H Kler, A Kashyap, SM Amrutkar, P Sharma, ...
RSC advances 6 (81), 77717-77734, 2016
332016
Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation
G Joshi, H Nayyar, S Kalra, P Sharma, A Munshi, S Singh, R Kumar
Chemical biology & drug design 90 (5), 995-1006, 2017
292017
E-pharmacophore guided discovery of pyrazolo [1, 5-c] quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase
G Joshi, S Kalra, UP Yadav, P Sharma, PK Singh, S Amrutkar, AJ Ansari, ...
Bioorganic Chemistry 94, 103409, 2020
282020
Synthesis and biological evaluation of new 2, 5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors
G Joshi, SM Amrutkar, AT Baviskar, H Kler, S Singh, UC Banerjee, ...
RSC advances 6 (18), 14880-14892, 2016
272016
Design, synthesis, biological evaluation of 3, 5-diaryl-4, 5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via …
G Joshi, M Sharma, S Kalra, NS Gavande, S Singh, R Kumar
Bioorganic Chemistry 107, 104620, 2021
252021
Anticancer potential of some imidazole and fused imidazole derivatives: Exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition
S Kalra, G Joshi, M Kumar, S Arora, H Kaur, S Singh, A Munshi, R Kumar
RSC Medicinal Chemistry 11 (8), 923-939, 2020
222020
Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
M Kumar, G Joshi, S Arora, T Singh, S Biswas, N Sharma, ZR Bhat, ...
Molecules 26 (5), 1490, 2021
212021
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
G Joshi, P Borah, S Thakur, P Sharma, Mayank, R Poduri
Human Vaccines & Immunotherapeutics 17 (12), 4714-4740, 2021
192021
Doxorubicin and Crocin Co-delivery by Polymeric Nanoparticles for Enhanced Anticancer Potential In Vitro and In Vivo
I Khan, G Joshi, B Sarkar, KT Nakhate, Ajazuddin, AK Mantha, R Kumar, ...
ACS Applied Bio Materials 3 (11), 7789-7799, 2020
192020
Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo [1, 5-c] quinazolines as potential EGFR inhibitors
AJ Ansari, G Joshi, UP Yadav, AK Maurya, VK Agnihotri, S Kalra, R Kumar, ...
Bioorganic Chemistry 93, 103314, 2019
192019
系统目前无法执行此操作,请稍后再试。
文章 1–20